Ovid Therapeutics (OVID) Research & Development (2016 - 2026)
Ovid Therapeutics (OVID) posted Research & Development of $9.96 million for Q2 2026, up 54.0% from $6.47 million a year earlier but down 10.9% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Research & Development (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Ovid Therapeutics was $33.6 million, up 24.9% year-over-year; for FY2025, it was $25.58 million, down 30.4% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -16.6% (FY2020 to FY2025).
- In prior years, Ovid Therapeutics' Research & Development was $36.77 million in FY2024 (+28.6%), $28.59 million in FY2023 (+16.1%), $24.62 million in FY2022 (+100.1%) and $12.3 million in FY2021 (-80.6%).
- Quarterly Research & Development has run from a low of -$16.55 million in Q4 2021 to a high of $12.58 million in Q2 2024 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last three quarters, with growth averaging 3.3% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2024, with growth of 109.7%; the weakest was Q3 2021, with a decline of 69.0%.
- According to Business Quant data, Research & Development for the three prior quarters was $11.18 million (Q1 2026), $6.59 million (Q4 2025) and $5.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Ovid Therapeutics | 454.50 Mn | 86.52 Mn | - | 9.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.96 Mn |
| Mar 31, 2026 | 11.18 Mn |
| Dec 31, 2025 | 6.59 Mn |
| Sep 30, 2025 | 5.87 Mn |
| Jun 30, 2025 | 6.47 Mn |
| Mar 31, 2025 | 6.66 Mn |
| Dec 31, 2024 | 5.92 Mn |
| Sep 30, 2024 | 7.86 Mn |
| Jun 30, 2024 | 12.58 Mn |
| Mar 31, 2024 | 10.40 Mn |
| Dec 31, 2023 | 10.64 Mn |
| Sep 30, 2023 | 5.33 Mn |
| Jun 30, 2023 | 6.00 Mn |
| Mar 31, 2023 | 6.62 Mn |
| Dec 31, 2022 | 5.56 Mn |
| Sep 30, 2022 | 5.18 Mn |
| Jun 30, 2022 | 6.05 Mn |
| Mar 31, 2022 | 7.83 Mn |
| Sep 30, 2021 | 4.92 Mn |
| Jun 30, 2021 | 7.68 Mn |
API Access
Ovid Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();